Skip to content
Visit the store
Organization profile · Supplement protocol brand

STEMREGEN

Release, Signal, Mobilize and multi-product protocols · Individual bottles and bundled protocols

A supplement line organized around three named products—Release, Signal and Mobilize—sold individually and together in daily or accelerated protocols.

Signal
retail
Release
retail
Daily Protocol
retail
Accelerated
retail
Products, protocol contents, retail prices and research checkedReviewed

Who they are

Overview

STEMREGEN is a US supplement brand operated by Biomics, LLC and founded by researcher Christian Drapeau, who built the range around circulating stem cells. It sells three proprietary formulas, Release, Signal and Mobilize, individually or combined in two bundles: the Daily Repair Protocol, which contains all three, and the larger Accelerated Repair Protocol. The company's research centers on measuring circulating cell counts, and its own terms state that rigorous double-blind studies have not established the finished products' benefits or risks.

At a glance

The company, three-product structure and research limits that shape the purchase decision.

Legal operator
Biomics, LLC
The current terms identify Biomics, LLC doing business as STEMREGEN.
Core trio
The Daily Repair Protocol combines all three named products.Daily Repair Protocol
Retail commitment
Single products and multi-product protocols
One-time retail, sale and subscription options are priced differently; compare like with like.

Company claims

  • Recovery and energy

    STEMREGEN markets its supplements with the promise of faster recovery, renewed energy and restored movement.

  • Circulating stem cells

    STEMREGEN says its products increase circulating stem cells, citing its clinical trials and ongoing studies.

Cost + commitment

Retail prices and protocol scale

One-time retail from

Signal at one-time retail. Daily Repair base retail is ; Accelerated Repair base retail is .

One-time consumer retail prices. Collection pages can show lower sale or subscription figures, which are not the one-time total; wholesale variants are separate.

Signal, Daily Repair and Accelerated Repair one-time retail prices checked 26 September 2026; Mobilize 7 September 2026; Release 31 August 2026.

Offerings

  • STEMREGEN store
    Price not published

    For consumers and professionals

    Individual products and combined protocols are sold online.

    Browse the STEMREGEN rangeLink verified

Formula + protocol logic

How the products differ

Release, Signal and Mobilize are separate proprietary formulas assigned different roles within the company's model.

  • Release

    Release

    STEMREGEN positions this formula around the release and migration of circulating stem cells.

  • Signal

    Signal

    The company assigns this plant-extract blend a signalling role in its three-product model.

  • Mobilize

    Mobilize

    The third distinct formula included with Release and Signal in both repair protocols.

Where + how to access

Availability and purchase routes

STEMREGEN sells retail products and protocols online, with region and customer route affecting what appears.

Retail route
Individual products and combined protocols are sold online.
Purchase options
One-time or subscription
Product pages offer a one-time purchase selector; sale and subscription amounts differ from one-time retail.
Wholesale route
Separate variants
Wholesale prices are separate from the consumer prices shown here.
Regional access
Destination-dependent
Use the correct store and checkout for currency, stock and delivery.
Protocols
Daily or AcceleratedDailyAccelerated
The two bundles differ in quantity, intensity and price.

Publicly identified people

Leadership and scientific voice

STEMREGEN publicly identifies a founder-scientist and current executive leader.

Expert & Voice

Founder and Chief Science Officer

Christian Drapeau

Scientist · Author · STEMREGEN founder

Christian Drapeau is a scientist, author and STEMREGEN founder known for books, lectures and research on circulating stem cells and endogenous stem-cell mobilisation.

Stem-cell biologyRegenerative healthMedicinal plants
View profile

Chief Executive Officer

Ryan Riley

Publicly identified as the current executive leader of STEMREGEN.

What helps you decide

Research claims in context

STEMREGEN’s research discussion centres on ingredients and measurements of circulating stem cells. Its terms state that rigorous double-blind studies have not established the benefits or risks of the finished products.

Research focus

  • The company’s research page links studies used to explain its circulating-cell model.

  • Release, Signal and Mobilize are separate formulas; the two protocols combine them in different quantities.

What this means for your choice

  • A change in circulating cell counts does not establish better recovery, tissue repair, disease treatment or longer life.

  • The available research does not establish that the higher-priced Accelerated Protocol provides greater benefit than the Daily Protocol.

  • Compare products and protocols on the same purchase option. One-time retail, sale and subscription amounts are different prices.

Common questions

Frequently asked questions

Transparency

Transparency and sources

Researched by Longevity.io

Reviewed

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.

Keep exploring

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint